Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on February 14, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print February 14, 2008, doi: 10.1161/ATVBAHA.107.154534
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/5/850    most recent
ATVBAHA.107.154534v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohler, E. R.
Right arrow Articles by Wilensky, R. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohler, E. R., III
Right arrow Articles by Wilensky, R. L
Right arrowPubmed/NCBI databases
*Gene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
*STREPTOZOTOCIN

Submitted on August 27, 2007
Accepted on January 30, 2008

Site-Specific Atherogenic Gene Expression Correlates With Subsequent Variable Lesion Development in Coronary and Peripheral Vasculature

Emile R. Mohler III ; Lea Sarov-Blat ; Yi Shi ; Damir Hamamdzic ; Andrew Zalewski ; Colin MacPhee ; Raul Llano ; Dan Pelchovitz ; Sumeet K. Mainigi ; Hashim Osman ; Troy Hallman ; Klaudia Steplewski ; Zachary Gertz ; Min Min Lu ; and Robert L Wilensky *

From the University of Pennsylvania (E.R.M., D.H., R.L., D.P., S.K.M., H.O., T.H., K.S., Z.G., M.M.L., R.L.W.), the Thomas Jefferson University (Y.S., A.Z.), and GlaxoSmithKline (L.S.-B., A.Z., C.M.), Philadelphia, Pa.

* To whom correspondence should be addressed. E-mail: robert.wilensky{at}uphs.upenn.edu.

Objectives—The relationship between specific gene regulation and subsequent development and progression of atherosclerosis is incompletely understood. We hypothesized that genes in the vasculature related to cholesterol metabolism, inflammation, and insulin signaling pathways are differentially regulated in a site-specific and time-dependent manner.

Methods and Results—Expression of 59 genes obtained from coronary, carotid, and thoracic aortic arteries were characterized from diabetic (DM)/hypercholesterolemic (HC) swine (n=52) 1, 3, and 6 months after induction. Lesion development in the 3 arterial beds was quantified and characterized at 1, 3, 6, and 9 months. Progressive lesion development was observed in the coronary > thoracic aorta>>carotid arteries. Genes involved in cholesterol metabolism and insulin pathways were upregulated in coronaries>thoracic aortae>carotids. Inflammatory genes were more markedly upregulated in coronary arteries than the other 2 arteries. Genes implicated in plaque instability (eg, matrix metalloproteinase-9, CCL2 and Lp-PLA2 mRNAs) were only upregulated at 6 months in coronary arteries.

Conclusions—Variable gene expression, both in regard to the arterial bed and duration of disease, was associated with variable plaque development and progression. These findings may provide further insight into the atherosclerotic process and development of potential therapeutic targets.


Key words: atherosclerosis • diabetes • hypercholesterolemia • animal models • mRNA